Espero BioPharma, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Espero BioPharma, Inc. - overview
Established
2017
Location
Jacksonville, FL, US
Primary Industry
Biotechnology
About
Established in 2017 as a result of the merger between Armetheon, Inc. and Espero Pharmaceuticals, Inc. , Espero BioPharma, Inc. is a biopharmaceutical company that focuses on the research and development of drugs for treating patients suffering from cardiorenal diseases.
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Cardiology, Pharmaceutical Research & Development, Biomaterials
Website
www.esperobio.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Espero BioPharma, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Merger | Completed | Armetheon, Inc., Espero Pharmaceuticals, Inc. | - |
Displaying 1 - 1 of 1
Espero BioPharma, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.